It'll Take New Tools And Partnerships To Fast-Track Clinical Trials For A COVID-19 R_X

By Larissa Comis

As we adjust to life under COVID-19, I wonder if things will ever be the same again. From my new home office in the dining room, a world that once seemed so small – just a day’s flight from one end of the globe to another – now seems out of reach. The impact of the pandemic on clinical trials across the world is also tremendous. Because clinical trials have traditionally been built on face-to-face visits, many of their aspects still rely on monitors’ onsite observations.

So where does the biopharma industry go from here?